Ncbp1-KO Mouse
一般名
Ncbp1-KO
製品ID
S-KO-10093
背景情報
C57BL/6JCya
系統ID
KOCMP-433702-Ncbp1-B6J-VA
状況
このマウス系統を論文で使用する場合は、「Ncbp1-KO Mouse（カタログ番号S-KO-10093）はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Ncbp1-KO
系統ID
KOCMP-433702-Ncbp1-B6J-VA
遺伝子名
製品ID
S-KO-10093
遺伝子別名
CBP80
遺伝子別名
C57BL/6JCya
NCBI ID
修正
Conventional knockout
染色体
Chr 4
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000030014
NCBIトランスクリプトID
NM_001033201
ターゲット領域
Exon 2~8
有効領域の大きさ
~9.1 kb
遺伝子研究の概要
Ncbp1, also known as Nuclear cap-binding protein 1, is essential for capped RNA processing and intracellular localization. It forms the nuclear Cap-Binding Complex (CBC) with NCBP2 and an alternative CBC with NCBP3, playing roles in RNA fate decisions, such as transcription, splicing, polyadenylation, and mRNA export [5,6,8]. It is also involved in translation as part of the nuclear cap-binding protein complex-dependent translation machinery [9].
In disease-related research, NCBP1 shows diverse impacts. In diffuse large B-cell lymphoma (DLBCL), its elevated expression is associated with poor prognosis, and it promotes cell proliferation via the METTL3-mediated m6A modification of c-Myc [1]. In lung adenocarcinoma, NCBP1 overexpression promotes cancer cell growth, migration, etc., by up-regulating CUL4B [3]. In breast cancer, NCBP1 is identified as a prognostic and immune-associated biomarker, and knockdown of it suppresses malignancy in vitro [7]. In renal tubular epithelial cells, the IGF2BP3/NCBP1 complex inhibits senescence by regulating CDK6 mRNA stability [2]. Conversely, in epilepsy, NCBP1 is downregulated in the epileptic hippocampus, and its overexpression improves cognitive function by reducing oxidative stress, neuronal loss, and glial activation [4].
In conclusion, Ncbp1 is crucial for RNA-related processes and is implicated in multiple diseases. Studies on Ncbp1, including those using in vitro knockdown models, have provided insights into its roles in cancer, renal senescence, and epilepsy, potentially guiding the development of targeted therapies for these conditions.
References:
1. Meng, Sibo, Xia, Yuan, Li, Mingying, Sun, Tao, Ji, Chunyan. 2023. NCBP1 enhanced proliferation of DLBCL cells via METTL3-mediated m6A modification of c-Myc. In Scientific reports, 13, 8606. doi:10.1038/s41598-023-35777-2. https://pubmed.ncbi.nlm.nih.gov/37244946/
2. Li, Yaqin, Luo, Congwei, Cai, Yating, Wang, Hongsheng, Niu, Hongxin. 2024. IGF2BP3/NCBP1 complex inhibits renal tubular senescence through regulation of CDK6 mRNA stability. In Translational research : the journal of laboratory and clinical medicine, 273, 1-15. doi:10.1016/j.trsl.2024.06.004. https://pubmed.ncbi.nlm.nih.gov/38945255/
3. Zhang, Huijun, Wang, An, Tan, Yulong, Chen, Xiaofeng, He, Zelai. 2019. NCBP1 promotes the development of lung adenocarcinoma through up-regulation of CUL4B. In Journal of cellular and molecular medicine, 23, 6965-6977. doi:10.1111/jcmm.14581. https://pubmed.ncbi.nlm.nih.gov/31448526/
4. Gao, Xiaoying, You, Zhipeng, Huang, Cong, Qi, Sihua, Sun, Jiahang. 2023. NCBP1 Improves Cognitive Function in Mice by Reducing Oxidative Stress, Neuronal Loss, and Glial Activation After Status Epilepticus. In Molecular neurobiology, 60, 6676-6688. doi:10.1007/s12035-023-03497-3. https://pubmed.ncbi.nlm.nih.gov/37474884/
5. Dou, Yuhui, Barbosa, Isabelle, Jiang, Hua, LaCava, John, Jensen, Torben Heick. . NCBP3 positively impacts mRNA biogenesis. In Nucleic acids research, 48, 10413-10427. doi:10.1093/nar/gkaa744. https://pubmed.ncbi.nlm.nih.gov/32960271/
6. Gebhardt, Anna, Habjan, Matthias, Benda, Christian, Habermann, Bianca, Pichlmair, Andreas. 2015. mRNA export through an additional cap-binding complex consisting of NCBP1 and NCBP3. In Nature communications, 6, 8192. doi:10.1038/ncomms9192. https://pubmed.ncbi.nlm.nih.gov/26382858/
7. Li, Jianrong, Zheng, Lin, Song, Liying, Bai, Wenqi, Qi, Liqiang. 2023. Identification and validation of N7 -methylguanosine-associated gene NCBP1 as prognostic and immune-associated biomarkers in breast cancer patients. In Journal of cellular and molecular medicine, 28, e18067. doi:10.1111/jcmm.18067. https://pubmed.ncbi.nlm.nih.gov/38071502/
8. Clarke, Bradley P, Angelos, Alexia E, Mei, Menghan, Xie, Yihu, Ren, Yi. 2024. Cryo-EM structure of the CBC-ALYREF complex. In eLife, 12, . doi:10.7554/eLife.91432. https://pubmed.ncbi.nlm.nih.gov/39282949/
9. Park, Yeonkyoung, Park, Joori, Kim, Yoon Ki. 2017. Crosstalk between translation and the aggresome-autophagy pathway. In Autophagy, 14, 1079-1081. doi:10.1080/15548627.2017.1358849. https://pubmed.ncbi.nlm.nih.gov/28837386/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。